Support for the preparation of the GC8 funding application to the Global Fund in Senegal
February 2026 – November 2026
Senegal
Context:
In Senegal, HIV, Tuberculosis (TB) and malaria represent major public health challenges.
– While the prevalence of HIV in the general population remains low at 0.29%, the epidemic remains concentrated among key populations: Sex workers (SW) (5.9% in 2019), men who have sex with other men (MSM) (27.6% in 2017), and people who inject drugs (PID) (9.2% in 2011). Sexually transmitted infections (STIs) are also an under-documented and under-funded public health issue, despite their high prevalence.
– At the same time, HIV/TB co-infection remains significant. TB has an incidence of approximately 110 to 113 cases per 100 000 inhabitants in 2023 and a treatment success rate of close to 90% diagnoses cases. The tuberculosis mortality rate remains relatively constant, with a slight increase between 2015 and 2021.
– Finally, malaria remains a public health problem in Senegal, with an estimated 995 763 cases in 2021 and mortality rate of 59 cases per 100 000 inhabitants. Dakar, Diourbel, Kaolack, Kedougou, Kolda, and Tambacounda, which account for 52% of the population, bear the brunt of the malaria burden, with 90% of cases and 74% of deaths. Children under five, pregnant women, and rural and mobile populations are disproportionately affected by malaria and face barriers that hinder their access to prevention, diagnosis, and treatment services.
Since 2023, these diseases have been the subject of an integrated National strategic Plan (2023-2030) that promotes a person-cantered and life-cycle approach based on differentiated service delivery model, including for communities. In line with the strengthened integration approach reflected in the updated NSIP for the period of 2026-2030, a joint HIV/TB/Malaria/HSS funding application will be submitted by Senegal for the Global Fund’s 8th grant cycle (CG8). While the preparation of the CG8 funding application is taking place within a profoundly renewed framework, marked by generally more constrained allocations, a reinforced requirement for prioritization, and the introduction of new tools and submission processes, three expert assessments are being funded by Expertise France to support the CCM throughout the process.
Overall objective:
Support the Writing Committee in preparing Senegal’s GC8 funding application to the Global Fund, using the forms designed for this purpose, while complying with the framework and deadlines set by the CCM, the Global Fund’s application instructions, and any other necessary supplementary documents.
Methodology:
– Step 1: Framing of the mission
– Step 2: Supporting country dialogue, particularly at the community level
– Step 3: Supporting the Writing Committee in drafting the funding application and its annexes.
– Step 4: Responding to requests for clarification from the Global Fund country team and the Technical Review Panel (TRP)
– Step 5: Support for the grant negotiation process – Grant Making
– Step 6: Participation in the Expertise France survey and closure of the mission
Beneficiaries
-
National coordinating body (CCM) of the Global Fund
Results
-
R1: The funding application has been developed in a participatory and inclusive manner for all actors involved in the fight against pandemics (including representatives of civil society and key and vulnerable populations) within the specified time frame, and proposes an effective and inclusive intervention strategy that complements other funding.
-
R2: The funding application proposes a strategy to strengthen the national health system, including at the community level, in order to ensure continuity of services, with a particular focus on removing barriers related to gender and human rights.